the new epilepsy drug, Potiga (poe-TEE-ga, ezogabine)

October 2012

Please see the October 2013 FDA Drug Safety Communication regarding Potiga and skin discoloration/retinal abnormalities

You'll soon see the new epilepsy drug, Potiga (poe-TEE-ga, ezogabine), hit your pharmacy.

Don't expect Potiga to fly off your shelves. It's dosed THREE times a day...costs over $700/month...and comes with some unusual side effects.

Give out a with outpatient Rxs...to meet the Risk Evaluation and Mitigation Strategies (REMS) program requirement for alerting patients to Potiga's risk of causing urinary problems.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Psychiatry confusion about which diclofenac product to dispense
Education and Training how and why you need to get your "e-Profile ID" to meet the new CE reporting requirements
OTC Products The new OTC asthma inhaler, Asthmanefrin (racepinephrine), will be promoted as an alternative to Primatene Mist (epinephrine)
Substance Use Disorder more people abusing Suboxone tabs
Overactive Bladder a new drug for overactive bladder called Myrbetriq
Diabetes Meds MORE controversy about using pioglitazone (Actos) for type 2 diabetes
Antipsychotics whether it's okay to combine antipsychotics
Hypertension buzz about when drugs should be started in patients with MILD hypertension
Vaccines New virus strains in the 2012-2013 influenza vaccine
Anticonvulsants the new epilepsy drug, Potiga (poe-TEE-ga, ezogabine)
Infectious Diseases This will be the worst year yet for West Nile virus
Depression more emphasis on treating depression in heart patients
Communication helping patients who speak little to no English